2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Jae Seung Kim: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease [18F]PI-2620 - Cognitively Normal, Mild Cognitive Impairment | Phase 2 | Completed | Jae Seung Kim | 84 | 2019-04-09 | 2023-09-06 |
| [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease [18F]THK-5351 - Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 | Completed | Jae Seung Kim | 135 | 2016-01-11 | 2020-12-14 |
Alzheimer Disease (2) · Cognitive Dysfunction (2) · Nerve Degeneration (1) · Neurodegenerative Diseases (1) · Pick Disease of the Brain (1) · Tauopathies (1)
((18)F)PI-2620 (1) · THK5351 (1)
South Korea (2)